IRCT20200117046158N1RecruitingPhase 3
Evaluation of the effect of allopurinol on nephropathy in diabetic patients
Shahre-kord University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- All
Inclusion Criteria
- •24-hour urine protein greater than 150mg / dl
- •Uric acid between 6 and 15
- •Informed patient satisfaction
- •The severity of diabetic nephropathy is similar in both groups
- •Passive urine sedimentation
Exclusion Criteria
- •Patients treated with allopurinol
- •Patients with significant renal failure (Cr> 3 mg / dl) or (GFR <25cc / min)
Investigators
Similar Trials
Completed
Not Applicable
Effect of Allopurinol on renal residual functioIRCT20090905002417N20Esfahan University of Medical Sciences98
Completed
Not Applicable
Effect of Allopurinol on Chronic Kidney Disease Progression.Chronic renal failure.Chronic renal failureIRCT2015101714333N43Vice chancellor for research, Kermanshah University of Medical Sciences180
Not yet recruiting
Phase 3
Evaluation of the effect of Allopurinol on the frequency of ventricular and supraventricular arrhythmiasCondition 1: Ventricular arrhythmias. Condition 2: Supraventricular arrhythmia.Re-entry ventricular arrhythmiaI47.0I47.1Supraventricular tachycardiaIRCT20120520009801N12Mashhad University of Medical Sciences134
Active, not recruiting
Phase 1
Estudio para valorar el efecto sobre las plaquetas del tratamiento con Alopurinol en pacientes diabéticosEUCTR2011-000619-16-ESFundación Investigación Biomedica. Hospital Clinico San Carlos
Completed
Phase 2
Evaluation of the effect of Allopurinol in reducing heart damage in acute ischemic heart patientsIRCT20111206008307N36Tabriz University of Medical Sciences100